We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AGEN market cap is 111.53M. The company's latest EPS is USD -11.4025 and P/E is -0.45.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25.3M | 24.32M | 84.36M | 28.01M | 23.51M |
| Operating Income | -54.66M | -46.34M | -3.8M | -32.88M | -30.19M |
| Net Income | -69.07M | -62.25M | -46.34M | -61.94M | -53.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 150.05M | 88.17M | 295.67M | 98.84M | 156.87M |
| Operating Income | -70.14M | -117.24M | 25.75M | -179.43M | -159.55M |
| Net Income | -107.87M | -181.12M | -24.14M | -220.29M | -245.97M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 383.59M | 335.47M | 313.91M | 256.56M | 292.42M |
| Total Liabilities | 460.35M | 450.76M | 462.3M | 446.88M | 513.25M |
| Total Equity | -76.76M | -115.29M | -148.38M | -190.32M | -220.84M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 155.34M | 214.51M | 465.96M | 413.56M | 313.91M |
| Total Liabilities | 359.76M | 399.1M | 418.05M | 468.46M | 462.3M |
| Total Equity | -231.34M | -211.5M | 47.91M | -54.9M | -148.38M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -118.57M | -180.37M | -224.2M | -38.19M | -76.37M |
| Investing | -10.97M | 576k | 3.4M | 229k | -8k |
| Financing | 94.51M | 129.73M | 119.87M | 14.83M | 93.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.68M | -139.1M | 10.15M | -175.37M | -224.2M |
| Investing | -4.66M | -4.44M | -43.15M | -33.61M | 3.4M |
| Financing | 31.32M | 183.86M | 225.26M | 95.83M | 119.87M |
| Market Cap | 111.53M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 0.71 |
| Price to Cash Ratio | 1.47 |
| Price to Book Ratio | -0.75 |
| Dividend Yield | - |
| Shares Outstanding | 21.57M |
| Average Volume (1 week) | 555.78k |
| Average Volume (1 Month) | 386.3k |
| 52 Week Change | -77.52% |
| 52 Week High | 23.60 |
| 52 Week Low | 4.41 |
| Spread (Intraday) | 0.12 (2.32%) |
| Company Name | Agenus Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.agenusbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
